Literature DB >> 32848453

Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study.

Jianxing Zeng1,2,3, Kongying Lin4, Huocheng Liu1, Yao Huang1,2,3, Pengfei Guo4, Yongyi Zeng1,2,3, Jinhua Zeng1,2,3, Jingfeng Liu1,2,3.   

Abstract

BACKGROUND: The prognosis of young and older patients with hepatocellular carcinoma (HCC) is controversial. We aim to compare the clinicopathological features and prognosis of young (age ≤40 years) versus older patients (aged >40 years) with hepatitis B virus (HBV)-related HCC after curative resection.
METHODS: A total of 4504 patients with HBV-related HCC who underwent curative resection were included in this study and divided into young group (n=699) and older group (n=3805). Subgroup analyses were conducted to compare. Independent risk factors were identified by Cox regression analysis.
RESULTS: Young patients had better ALBI grade, lower rates of liver cirrhosis, higher rates of elevated serum AFP levels, larger tumor size, higher rates of microvascular invasion and macrovascular invasion, higher rates of Edmondson grade III-IV, lower rates of tumor capsular, more advanced AJCC TNM stages and more advanced BCLC stages than older patients (All p<0.05). Meanwhile, young patients had a worse overall survival (OS) rate (p=0.0091) and a worse recurrence-free survival (RFS) rate (p=0.045) than older patients. Multivariate analysis revealed that AFP, resection margin, tumor size, tumor capsular, and macrovascular invasion were associated with OS. The independent risk factors associated with RFS were ALB, tumor size, microvascular invasion, and macrovascular invasion.
CONCLUSION: Young patients had better liver function, more aggressive tumor characteristics, and worse prognosis than older patients. A tumor size of ≥5 cm and macrovascular invasion were associated with poor OS and RFS in young patients. If tumors could be detected at the early stage by more frequent surveillance, long-term survival can be expected in the young patients.
© 2020 Zeng et al.

Entities:  

Keywords:  hepatectomy; hepatocellular carcinoma; older; prognosis; young

Year:  2020        PMID: 32848453      PMCID: PMC7425652          DOI: 10.2147/CMAR.S261368

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


  33 in total

1.  Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy.

Authors:  Junyi Shen; Chuan Li; Lvnan Yan; Bo Li; Mingqing Xu; Jiayin Yang; Wentao Wang; Tianfu Wen
Journal:  Ann Hepatol       Date:  2018 January-February       Impact factor: 2.400

2.  The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis.

Authors:  Chien-Wei Su; Hao-Jan Lei; Gar-Yang Chau; Hung-Hsu Hung; Jaw-Ching Wu; Cheng-Yuan Hsia; Wing-Yiu Lui; Yu-Hui Su; Chew-Wun Wu; Shou-Dong Lee
Journal:  Arch Surg       Date:  2011-10-17

3.  Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening.

Authors:  Albert C Y Chan; Ronnie T P Poon; Kelvin K C Ng; Chung Mau Lo; Sheung Tat Fan; John Wong
Journal:  Ann Surg       Date:  2008-04       Impact factor: 12.969

4.  A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients.

Authors:  Cho Rok Lee; Jin Hong Lim; Sung Hoon Kim; Sang Hoon Ahn; Young Nyun Park; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-19       Impact factor: 3.452

5.  Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients.

Authors:  Chien-Hung Chen; Ting-Tsung Chang; Ken-Sheng Cheng; Wei-Wen Su; Sheng-Shun Yang; Hans Hsienhong Lin; Shun-Sheng Wu; Chuan-Mo Lee; Chi-Sin Changchien; Chien-Jen Chen; Jin-Chuan Sheu; Ding-Shinn Chen; Sheng-Nan Lu
Journal:  Liver Int       Date:  2006-09       Impact factor: 5.828

6.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

Review 7.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

8.  Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.

Authors:  Li Zhou; Jing-An Rui; Wei-Xun Zhou; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  Pathol Res Pract       Date:  2017-03-08       Impact factor: 3.250

9.  Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening.

Authors:  C-M Lam; A O O Chan; P Ho; I O-L Ng; C M Lo; C L Liu; R T P Poon; S T Fan
Journal:  Aliment Pharmacol Ther       Date:  2004-04-01       Impact factor: 8.171

10.  Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).

Authors:  Jian Zhou; Hui-Chuan Sun; Zheng Wang; Wen-Ming Cong; Jian-Hua Wang; Meng-Su Zeng; Jia-Mei Yang; Ping Bie; Lian-Xin Liu; Tian-Fu Wen; Guo-Hong Han; Mao-Qiang Wang; Rui-Bao Liu; Li-Gong Lu; Zheng-Gang Ren; Min-Shan Chen; Zhao-Chong Zeng; Ping Liang; Chang-Hong Liang; Min Chen; Fu-Hua Yan; Wen-Ping Wang; Yuan Ji; Wen-Wu Cheng; Chao-Liu Dai; Wei-Dong Jia; Ya-Ming Li; Ye-Xiong Li; Jun Liang; Tian-Shu Liu; Guo-Yue Lv; Yi-Lei Mao; Wei-Xin Ren; Hong-Cheng Shi; Wen-Tao Wang; Xiao-Ying Wang; Bao-Cai Xing; Jian-Ming Xu; Jian-Yong Yang; Ye-Fa Yang; Sheng-Long Ye; Zheng-Yu Yin; Bo-Heng Zhang; Shui-Jun Zhang; Wei-Ping Zhou; Ji-Ye Zhu; Rong Liu; Ying-Hong Shi; Yong-Sheng Xiao; Zhi Dai; Gao-Jun Teng; Jian-Qiang Cai; Wei-Lin Wang; Jia-Hong Dong; Qiang Li; Feng Shen; Shu-Kui Qin; Jia Fan
Journal:  Liver Cancer       Date:  2018-06-14       Impact factor: 11.740

View more
  2 in total

1.  Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study.

Authors:  Jia-Le Pu; Zhong Chen; Lan-Qing Yao; Ji-Ye Feng; Yong-Kang Diao; Ming-Cheng Guan; Ju-Dong Li; Zheng-Liang Chen; Ya-Hao Zhou; Hong Wang; Wei-Min Gu; Jie Li; Chao Li; Ming-Da Wang; Hong Zhu; Ying-Jian Liang; Feng Shen; Timothy M Pawlik; Wan Yee Lau; Tian Yang
Journal:  BJS Open       Date:  2022-01-06

2.  Prognostic Impact of Surgical Margin in Hepatectomy on Patients With Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies.

Authors:  Yeting Lin; Jiaxuan Xu; Jiaze Hong; Yuexiu Si; Yujing He; Jinhang Zhang
Journal:  Front Surg       Date:  2022-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.